The CELLg8® Advantage: Clinically-Proven Liposomal Delivery
Share
How CELLg8® Liposomes Raise Bioavailability
The effectiveness of any great formula comes down to one critical factor: bioavailability. It's not just what you take, but what your body can actually absorb.
CELLg8® is a next-generation, clinically-studied liposomal delivery system designed to solve the absorption challenge. By encapsulating active ingredients in protective lipid layers, it shields them from harsh stomach acid. This allows for dramatically enhanced absorption, with clinical studies on various ingredients demonstrating that this delivery system can make them significantly more bioavailable than standard, non-liposomal formulas.[1]
Backed by Leading Expertise
The innovation behind CELLg8® comes from Dr. Emek Blair, PhD, a renowned chemist with a doctorate from the University of California, Irvine. Over the last two decades, Dr. Blair has perfected a unique, solvent-free method for fabricating custom liposome formulas.[2] His work has resulted in numerous accolades and has been published in multiple peer-reviewed clinical studies and scientific articles, establishing CELLg8® as a trusted and verifiable technology.
What This Means For You
Standard supplement capsules — regardless of ingredient quality — are absorbed by the body at roughly 10% of the stated dose. The rest is broken down by stomach acid and digestive enzymes before it ever reaches your bloodstream. For most supplements, this means the dose printed on the label is not the dose your cells actually receive.
CELLg8® liposomal delivery changes that equation. By encasing active ingredients in a lipid shell that mirrors your own cell membranes, it protects them through the digestive process and allows for absorption of up to 10 times more than standard capsules — potentially delivering close to the full stated dose.
A Concrete Example: NAD+7 and NR Dosage
The most common NR supplements on the market use around 300mg of NR per serving delivered in standard capsule form. At ~10% absorption, a typical serving delivers roughly 30mg of NR to your cells — regardless of what the label states.
NAD+7 uses 325mg of NR (Men's) and 310mg of NR (Women's) — a higher dose to begin with. With patented CELLg8® liposomal delivery and Bioperine, absorption can reach up to 10× — meaning your body may absorb close to the full 310mg or 325mg rather than ~10% of it.
More of the right ingredient, delivered where it actually works.
By utilizing this advanced liposomal system in our formulas, we ensure that the powerful ingredients are delivered to your bloodstream efficiently and effectively — turning a great formula into an exceptional one.
References
-
Shade, C. W. (2016). Liposomes as Advanced Delivery Systems for Nutraceuticals. Integrative Medicine: A Clinician's Journal, 15(1), 33–36.
This review article provides a general scientific overview of how liposomal delivery enhances the bioavailability of supplements. -
Shade, C., & Blair, E. (2016). U.S. Patent No. 9,259,404 B2. Washington, DC: U.S. Patent and Trademark Office.
This is the official U.S. Patent granted to Dr. Emek Blair and Dr. Christopher Shade for the unique, solvent-free method of producing liposomes, confirming Dr. Blair's role as a **co-inventor** of the technology used in CELLg8®.
